XenoPort to Present at the Morgan Stanley Global Healthcare Conference
September 02 2014 - 11:00AM
Business Wire
XenoPort, Inc. (Nasdaq:XNPT) announced today that it will
provide access via the World Wide Web to its presentation at the
Morgan Stanley Global Healthcare Conference. The live presentation
will occur at 1:40 p.m. Pacific Time (4:40 p.m. Eastern Time) on
Tuesday, September 9, 2014. A replay of the presentation will also
be available.
To access the live presentation via the Web, please go to
www.XenoPort.com. Please connect to the Website at least 15 minutes
prior to the live presentation to ensure adequate time for any
software downloads that may be necessary to listen to the
Webcast.
A replay of the Webcast can be accessed for a minimum of one
month and will be available approximately 24 hours after the live
presentation.
About XenoPort
XenoPort, Inc. is a biopharmaceutical company focused on
developing and commercializing a portfolio of internally discovered
product candidates for the potential treatment of neurological
disorders. XenoPort is currently commercializing HORIZANT®
(gabapentin enacarbil) Extended-Release Tablets in the United
States and developing its novel fumaric acid ester product
candidate, XP23829, as a potential treatment for patients with
moderate-to-severe chronic plaque-type psoriasis and/or relapsing
forms of Multiple Sclerosis. REGNITE® (gabapentin enacarbil)
Extended-Release Tablets is being marketed in Japan by Astellas
Pharma Inc. XenoPort recently granted exclusive world-wide rights
for the development and commercialization of its clinical-stage
oral product candidate, arbaclofen placarbil, to Reckitt Benckiser
Pharmaceuticals, Inc. for all indications. XenoPort's pipeline of
product candidates also includes a potential treatment for patients
with Parkinson's disease.
To learn more about XenoPort, please visit the website at
www.XenoPort.com.
HORIZANT, REGNITE and XENOPORT are registered trademarks of
XenoPort, Inc.
XNPT2G
XenoPort, Inc.Jackie Cossmon, 408-616-7220ir@XenoPort.com
Xenoport, Inc. (NASDAQ:XNPT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Xenoport, Inc. (NASDAQ:XNPT)
Historical Stock Chart
From Apr 2023 to Apr 2024
